1. Home
  2. ICUI vs TPC Comparison

ICUI vs TPC Comparison

Compare ICUI & TPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • TPC
  • Stock Information
  • Founded
  • ICUI 1984
  • TPC 1894
  • Country
  • ICUI United States
  • TPC United States
  • Employees
  • ICUI N/A
  • TPC N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • TPC General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • ICUI Health Care
  • TPC Consumer Discretionary
  • Exchange
  • ICUI Nasdaq
  • TPC Nasdaq
  • Market Cap
  • ICUI 3.0B
  • TPC 2.5B
  • IPO Year
  • ICUI 1992
  • TPC N/A
  • Fundamental
  • Price
  • ICUI $123.69
  • TPC $69.56
  • Analyst Decision
  • ICUI Buy
  • TPC Strong Buy
  • Analyst Count
  • ICUI 6
  • TPC 4
  • Target Price
  • ICUI $179.40
  • TPC $66.75
  • AVG Volume (30 Days)
  • ICUI 214.7K
  • TPC 565.4K
  • Earning Date
  • ICUI 11-06-2025
  • TPC 11-10-2025
  • Dividend Yield
  • ICUI N/A
  • TPC N/A
  • EPS Growth
  • ICUI N/A
  • TPC N/A
  • EPS
  • ICUI N/A
  • TPC N/A
  • Revenue
  • ICUI $2,372,504,000.00
  • TPC $4,770,779,000.00
  • Revenue This Year
  • ICUI N/A
  • TPC $24.11
  • Revenue Next Year
  • ICUI N/A
  • TPC $11.90
  • P/E Ratio
  • ICUI N/A
  • TPC N/A
  • Revenue Growth
  • ICUI 2.96
  • TPC 12.03
  • 52 Week Low
  • ICUI $107.00
  • TPC $18.34
  • 52 Week High
  • ICUI $196.26
  • TPC $71.07
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 55.19
  • TPC 65.18
  • Support Level
  • ICUI $119.74
  • TPC $62.00
  • Resistance Level
  • ICUI $124.17
  • TPC $71.07
  • Average True Range (ATR)
  • ICUI 3.35
  • TPC 2.76
  • MACD
  • ICUI 1.00
  • TPC 0.50
  • Stochastic Oscillator
  • ICUI 95.89
  • TPC 85.97

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.

Share on Social Networks: